Read real stories from people affected by MND, get inspired by the incredible ways people are supporting our cause and hear more about the latest advancements in research, care and support.
At MND Scotland, we know that investment in fundamental research is crucial in the hunt for potential MND therapies. Sometimes it takes a number of small discoveries to come together for progress to occur. A powerful example is our investment in early-stage research, which helped Professor Tom Gillingwater, at the University of Edinburgh, launch terazosin on its path to clinical trial.